Solid Dosage

Because our products are designed and built with system integration in mind, no matter which type of oral solid dosage (OSD) form you need to produce, we can help you to select the optimal solution.
By embracing digitalization, modularization, holistic product innovation and sustainability, we can supply both standard and custom-configured lines to suit specific projects. For example, fluid bed dryers and coaters can be combined with top- or bottom-drive high shear mixer/granulators, wet and dry milling facilities, product handling systems, binder and coating preparation units, filtration units and/or tablet presses. Furthermore, safety, containment, product flow and building requirements are fully incorporated for optimum process efficiency.
With a stronger focus on efficiency, Industry 4.0 and the environment, the pharmaceutical industry is evolving. GEA is committed to transforming tomorrow with better processes and has enthusiastically embraced these themes. For example, when the industry embraced continuous manufacturing to improve efficiencies and product quality, GEA was already bringing process-ready technology to the market.
And when it comes to digitalization, we’ve been innovating for years and bringing new services to customers, such as our virtual reality (VR)-based training modules. Ongoing product innovation, making our equipment better for the user and the planet, ensures that when you invest in a GEA process line, you’re making the right choice.
Отображение 4 из 28

Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.

The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.

Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.

At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.
Thanks to a new SmartParc manufacturing site, food processors in the U.K. are cutting their running costs and emissions. With GEA heating and cooling technology at its core, this collaborative production model demonstrates how innovation is accelerating the industry’s net-zero ambitions.
«Сварить яйца так же просто как и сварить пиво». Это такое сравнение, которое заставляет вас улыбнуться — и тут что-то щелкает в голове: что-то сложное вдруг становится простым. В этом фильме, действие которого происходит в сельскохозяйственной глубинке США, мы рассматриваем прецизионную ферментацию и реальную работу, необходимую для превращения идеи в продукты питания.